Prof. Hong-Cui Cao, MD, PhD, vice director of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, PI of Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University. The main research interest of Dr. Cao is focused on the research of cell therapy and liver diseases. She has published more than 70articles, owned 7 invention patents and owned more than 6state projects including Chinese High Tech Research & Development (863) Program and National Natural Science Foundation of China. She has been conducting placental-derived mesenchymal stem cells for the treatment of acute liver failure in Chinese miniature pigs earlier in the world. She and her group has also revealed the pathogenesis of liver failure and the mechanism of stem cell transplantation for liver disease such as liver failure, hepatic fibrosis，and acute liver injury using proteomics and metabolomics.